Yazar
Mark Andre Winderlich
3 cilt bulundu.
Cilt sonuçları
RE-MIND2: Comparative Effectiveness of Tafasitamab Plus Lenalidomide Versus Polatuzumab Vedotin/bendamustine/rituximab (pola-BR), CAR-T Therapies, and Lenalidomide/rituximab (R2) Based on Real-world Data in Patients with Relapsed/refractory Diffuse Large B-cell Lymphoma
Grzegorz S. Nowakowski, Dok Hyun Yoon, Patrizia Mondello, Erel Joffe, Anthea Peters, Isabelle Fleury, Richard Greil, Matthew Ku, Reinhard Marks, Kibum Kim, Pier Luigi Zinzani, Judith Trotman, Lorenzo Sabatelli, Eva E. Waltl, Mark Andre Winderlich, Andrea Sporchia, Nuwan C. Kurukulasuriya, Raul Cordoba, , · Yayınevi bilinmiyor
Correction To: RE-MIND2: Comparative Effectiveness of Tafasitamab Plus Lenalidomide Versus Polatuzumab Vedotin/bendamustine/rituximab (pola-BR), CAR-T Therapies, and Lenalidomide/rituximab (R2) Based on Real-world Data in Patients with Relapsed/refractory Diffuse Large B-cell Lymphoma
Grzegorz S. Nowakowski, Dok Hyun Yoon, Patrizia Mondello, Erel Joffe, Anthea Peters, Isabelle Fleury, Richard Greil, Matthew Ku, Reinhard Marks, , · Yayınevi bilinmiyor